Scarica l'app Stockscreener
1.95
22.64%
0.36
Dopo l'orario di chiusura:
1.98
0.03
+1.54%
Precedente Chiudi:
$1.59
Aprire:
$1.58
Volume 24 ore:
626.37K
Relative Volume:
1.22
Capitalizzazione di mercato:
$51.92M
Reddito:
$521.00K
Utile/perdita netta:
$-8.53M
Rapporto P/E:
-0.7569
EPS:
-2.5762
Flusso di cassa netto:
$-7.71M
1 W Prestazione:
+0.00%
1M Prestazione:
+0.00%
6M Prestazione:
-64.22%
1 anno Prestazione:
-29.41%
Intervallo 1D:
$1.57
$1.98
Intervallo di 1 settimana:
$1.57
$1.98
Portata 52W:
$1.11
$99.75
Novabay Pharmaceuticals Inc Stock (NBY) Company Profile
Nome
Novabay Pharmaceuticals Inc
Settore
Industria
Telefono
510-899-8800
Indirizzo
2000 Powell Street, Suite 1150, Emeryville, CA
Compare NBY vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NBY
Novabay Pharmaceuticals Inc
|
1.95 | 51.92M | 521.00K | -8.53M | -7.71M | -2.5762 |
VRTX
Vertex Pharmaceuticals Inc
|
447.54 | 113.70B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
614.78 | 65.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
835.99 | 52.14B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.98 | 40.73B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.48 | 32.87B | 742.00K | -1.37B | -1.07B | -7.0731 |
Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2019-09-18 | Iniziato | Ladenburg Thalmann | Buy |
| 2018-07-06 | Reiterato | H.C. Wainwright | Buy |
| 2017-11-15 | Reiterato | Laidlaw | Buy |
| 2017-06-05 | Iniziato | ROTH Capital | Buy |
| 2017-03-27 | Iniziato | Laidlaw | Buy |
| 2017-02-06 | Iniziato | Rodman & Renshaw | Buy |
| 2016-03-07 | Downgrade | Maxim Group | Buy → Hold |
| 2015-12-14 | Reiterato | Maxim Group | Buy |
| 2015-04-30 | Ripresa | Maxim Group | Buy |
| 2013-03-06 | Iniziato | Ascendiant Capital Markets | Strong Buy |
| 2008-01-03 | Iniziato | Dawson James | Speculative Buy |
Mostra tutto
Novabay Pharmaceuticals Inc Borsa (NBY) Ultime notizie
NovaBay Pharmaceuticals (NBY) Surges 22.6%: Key Levels to MonitorExtension Target - thelegaladvocate.com
NovaBay Pharmaceuticals (NBY) Jumps 22.6% as Trading Volume SurgesLow Risk Entry Stocks - Newser
NovaBay Pharmaceuticals, Inc. Common Stock (NY: NBY - FinancialContent
TradingKey - TradingKey
Pharmaceutical stock surges 26% after crypto pivot - MSN
NBY (NovaBay Pharmaceuticals) leadership outlines new clinical and commercial priorities following its latest quarterly earnings release.Dividend Increase - newser.com
Stablecoin Development Corp (Formerly NovaBay Pharmaceuticals) 2025 Annual 10-K/A Filing: Stock, Warrants, and Equity Transactions Overview - Minichart
Massive non-cash warrant error drives 2025 restatement at Stablecoin (NBY) - Stock Titan
NovaBay Pharmaceuticals to rebrand as Stablecoin Development Corporation - MSN
NovaBay rebrands to Stablecoin Development Corp in full crypto pivot—pharma company's stock climbs 19% - MSN
NovaBay enters into $6M securities purchase agreement with investor David Lazar - MSN
SDEV Stock Price, Quote & Chart | STABLECOIN DEVELOPMENT CORP (NYSEARCA:SDEV) - ChartMill
Director at Stablecoin Development Corp (SDEV) receives 140,000 RSU equity grant - Stock Titan
Is NovaBay Pharmaceuticals (NBY) stock a smart investment (Slight Rise) 2026-04-18Trending Momentum Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Tether backs Stablecoin Development Corporation’s $134 million private placement used to acquire SKY tokens - The Block
Tether says participated in a $134 million financing round for stablecoin development corporation - marketscreener.com
NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update - ADVFN
Aug Drivers: Can NovaBay Pharmaceuticals Inc sustain its profitabilityWeekly Risk Report & Smart Swing Trading Alerts - baoquankhu1.vn
What accelerates growth of NovaBay Pharmaceuticals (NBY) Stock | Price at $1.95, Up 22.64%Island Reversal - thelegaladvocate.com
NovaBay Pharmaceuticals, Inc. (NBY) - Minichart
Risk On: Is NovaBay Pharmaceuticals Inc stock a top performer YTD2026 Selloffs & Weekly Market Pulse Updates - baoquankhu1.vn
140K RSUs awarded to Stablecoin Development (SDEV) director Yenyou - Stock Titan
Stablecoin Development Corp (SDEV) CFO granted 300,000 RSUs vesting through 2029 - Stock Titan
NBY Technical Analysis & Stock Price Forecast - Intellectia AI
Price performance - Yahoo Finance Singapore
EBITDA margin % of NovaBay Pharmaceuticals, Inc. – BOATS:SDEV - TradingView — Track All Markets
NovaBay Pharmaceuticals, Inc. Statistics – BOATS:SDEV - TradingView
Net current asset value per share of NovaBay Pharmaceuticals, Inc. – BOATS:SDEV - TradingView
Equity in earnings of NovaBay Pharmaceuticals, Inc. – BOATS:SDEV - TradingView
NovaBay Pharmaceuticals, Inc. Dividends – BOATS:SDEV - TradingView
NovaBay Pharmaceuticals, Inc. Income Statement – BOATS:SDEV - TradingView
NovaBay Pharmaceuticals, Inc. Revenue Breakdown – BOATS:SDEV - TradingView
EBITDA per share of NovaBay Pharmaceuticals, Inc. – AMEX:SDEV - TradingView
Operating cash flow per share of NovaBay Pharmaceuticals, Inc. – AMEX:SDEV - TradingView
Price to book ratio of NovaBay Pharmaceuticals, Inc. – AMEX:SDEV - TradingView
Long term debt to total equity ratio of NovaBay Pharmaceuticals, Inc. – AMEX:SDEV - TradingView
Revenue per share of NovaBay Pharmaceuticals, Inc. – AMEX:SDEV - TradingView
Free cash flow per share of NovaBay Pharmaceuticals, Inc. – AMEX:SDEV - TradingView
NovaBay Pharmaceuticals, Inc. Balance Sheet – AMEX:SDEV - TradingView
NovaBay Pharmaceuticals, Inc. Financial Statements – AMEX:SDEV - tradingview.com
What are the risks of holding NovaBay Pharmaceuticals Inc2026 Weekly Recap & Intraday High Probability Alerts - baoquankhu1.vn
Stablecoin Development Corporation (SDEV) Focuses on Long-Term Growth in Digital Asset Ecosystems and Sky Protocol Staking 14 - Minichart
Three new option listings and three option delistings on April 6th - TipRanks
Stablecoin Development Corp (NYSE: SDEV) pivots to SKY-focused digital asset strategy - Stock Titan
Stablecoin Development Corporation Begins Trading on NYSE American Under Ticker 'SDEV” - The Manila Times
Stablecoin Development Corporation Begins Trading on NYSE American Under Ticker “SDEV” - marketscreener.com
New SDEV ticker arrives with 2.15B SKY tokens on its books - Stock Titan
Big Picture: Does NovaBay Pharmaceuticals Inc offer margin of safetyQuarterly Earnings Report & Reliable Intraday Trade Plans - baoquankhu1.vn
Stablecoin Development Corp: A $134M Bet on SKY Staking Yields - Bitget
SDEV Stock Price and Chart — AMEX:SDEV - TradingView
NBY Stock Analysis: NovaBay Pharmaceuticals Inc gains 22.64% to trade at 1.95 - Newser
Novabay Pharmaceuticals Inc Azioni (NBY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.37%
1.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):